BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2017
View Archived Issues
FDA awards orphan drug status to SPR-001 for congenital adrenal hyperplasia
Read More
National Cancer Center Japan testing DS-8201 in uterine carcinosarcoma
Read More
Clementia initiates phase III study of palovarotene for fibrodysplasia ossificans progressive
Read More
Novel ex vivo cell and gene therapy regenerates entire human epidermis in patient with JEB
Read More
Low-dose LMTM monotherapy may improve Alzheimer's disease impairments
Read More
Positive data reported from immunotherapy combination study of DPX-Survivac
Read More
Pimozide stabilizes neuromuscular junction transmission in patients with ALS
Read More
ChemomAb raises funds to support development of lead product
Read More
Janssen Biotech exercises option to collaborate with Idorsia on aprocitentan
Read More
Nexus BioPharma licenses rights to KV-001 for rapid reduction of adipose tissue
Read More
ObsEva begins proof-of-concept trial of OBE-022
Read More
Phase III data show efficacy of LMWF-5A in severe knee osteoarthritis
Read More
TAK-935/OV-935 obtains orphan drug status in U.S. for Dravet syndrome
Read More
First patient dosed in Novan's phase Ib study of SB-414 in atopic dermatitis
Read More
New phase I/II trial to study abexinostat with ibrutinib in relapsed or refractory DLBCL or MCL
Read More
Galectin Therapeutics reports positive results from phase IIb study of GR-MD-02
Read More
FDA approves Novo Nordisk's Ozempic for type 2 diabetes
Read More
National University of Singapore and Academia Sinica patent dual JAK-2/HDAC6 inhibitors
Read More
Novel anti-TSHR chimeric antigen receptors identified at the University of Florida
Read More
Exicure presents novel antisense oligonucleotides targeteing IL-17RA
Read More
Phase II study of MGL-3196 in NASH meets primary endpoint
Read More
Shire enters agreement with Rani Therapeutics to study Rani Pill technology
Read More
FDA grants orphan drug designation to STP-705 for cholangiocarcinoma
Read More
FDA grants full approval to Avastin for recurrent glioblastoma in adults
Read More
FDA grants priority review for rucaparib sNDA for maintenance therapy in ovarian cancer
Read More
Novartis commences tender offer for Advanced Accelerator Applications
Read More
VE-303 begins first-in-human study, awarded U.S. orphan drug designation
Read More
New phase I trial studies DNX-2401 in pediatric diffuse intrinsic pontine glioma
Read More
